Since NF-κB contributes to breast cancer growth and metastasis, weassessed the effect of genistein on this transcription factor.Treatment with ganetespib decreased NF-κB expression levels inthe nucleus (Figure 5) and inhibited translocation of NF-κB to thenucleus, as shown in both breast cancer cell lines. This evidence concerns the gene NFKB1 and breast carcinoma.